B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | WebDisclosure

Basculer en Français

10603	Companies
225009	Keywords
153732	Articles
119071	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

BRIEF

published on 02/25/2026 at 07:35, 3 months 23 days ago

BRAIN Biotech Reports Q1 Results and SolasCure's Clinical Milestone

Financial Performance BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
PRESS RELEASE

published on 02/25/2026 at 07:30, 3 months 23 days ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 01/14/2026 at 07:35, 5 months 6 days ago

BRAIN Biotech AG Shows Resilience Amid Economic Challenges in FY 2024/25

Revenue Decline BRAIN Biotech AG Cost Control Financial Year 2024/25 BRAINBioIncubator
BRIEF

published on 01/14/2026 at 07:35, 5 months 6 days ago

BRAIN Biotech AG fait preuve de résilience face aux défis économiques de l'exercice 2024/25

Baisse Des Revenus BRAIN Biotech AG Contrôle Des Coûts Exercice Financier 2024/25 Incubateur BRAINBio
PRESS RELEASE

published on 01/14/2026 at 07:30, 5 months 6 days ago

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
BRAIN Biotech AG reports FY 2024/25 financial results showing successful project monetization and cost control measures. Decline in revenues offset by strong cash position

Financial Results Revenue Decline BRAIN Biotech AG Cost Control Project Monetization
BRIEF

published on 09/03/2025 at 09:35, 9 months 17 days ago

BRAIN Biotech AG nomme Johan Jansén-Storbacka au poste de vice-président exécutif

Biotechnologie BRAIN Biotech AG Nomination De L'exécutif Johan Jansén-Storbacka Produits Enzymatiques
BRIEF

published on 09/03/2025 at 09:35, 9 months 17 days ago

BRAIN Biotech AG Names Johan Jansén-Storbacka as EVP

Biotechnology BRAIN Biotech AG Executive Appointment Johan Jansén-Storbacka Enzyme Products
PRESS RELEASE

published on 09/03/2025 at 09:30, 9 months 17 days ago

BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business
BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business on September 1, 2025, succeeding Rod Sears-Black. Johan brings 20+ years of biotechnology experience

BRAIN Biotech Executive Vice President Johan Jansén-Storbacka Enzyme Products Biocatalysts
BRIEF

published on 08/28/2025 at 07:35, 9 months 23 days ago

BRAIN Biotech Reports Solid Q3 Revenue Growth in BRAINBiocatalysts Segment

Financial Results BRAIN Biotech AG Enzyme Business BRAINBiocatalysts Q3 Revenue Growth
BRIEF

published on 08/28/2025 at 07:35, 9 months 23 days ago

BRAIN Biotech annonce une solide croissance de son chiffre d'affaires au troisième trimestre dans le segment BRAINBiocatalysts

Résultats Financiers BRAIN Biotech AG Entreprise D'enzymes CERVEAUBiocatalyseurs Croissance Du Chiffre D'affaires Au Troisième Trimestre

Accesswire

Published on 06/20/2026 at 01:00, 20 hours 19 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 21 hours 19 minutes ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 16 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 19 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 20 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 06:00, 15 hours 18 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 1 hour ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 1 hour ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 2 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 1 day 2 hours ago

Designated Person Notification

Les Echos

Published on 06/19/2026 at 19:33, 1 day 1 hour ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 1 hour ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 1 hour ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 1 hour ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 2 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE